Nurix Therapeutics, Inc. NRIX
16.44 USD +0.30 (+1.86%)
Nov 10, 2026, 10:18 AM EST
15.98 Day range 16.76
12.01 52-week range 28.23
- YTD
- -13.34%
- 1 year
- +34.20%
NRIX revenue history
Revenue is income from the company’s ordinary business activities.
83,980,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-11-30 | 83,980,000 | 29,431,000 | 53.95% |
| FY 2024 | 2024-11-30 | 54,549,000 | -22,438,000 | -29.15% |
| FY 2023 | 2023-11-30 | 76,987,000 | 38,360,000 | 99.31% |
| FY 2022 | 2022-11-30 | 38,627,000 | 8,877,000 | 29.84% |
| FY 2021 | 2021-11-30 | 29,750,000 | 11,930,000 | 66.95% |
| FY 2020 | 2020-11-30 | 17,820,000 | -13,295,000 | -42.73% |
| FY 2019 | 2019-11-30 | 31,115,000 | 31,115,000 | Not meaningful |
| FY 2018 | 2018-11-30 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-07-13T06:02:05.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.